Betty Lau

Betty Lau

Auto-generated profile, based on publicly available information

Betty Lau

MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2014 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
Mark R. WillsMark R. Wills
Mark R. Wills
EPEmma Poole
Emma Poole
BLBetty Lau
Betty Lau
BKBenjamin Krishna
Benjamin Krishna
JSJohn H Sinclair
John H Sinclair

24 April 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
EWEddie CY Wang
Eddie CY Wang
MPMariana Pjechova
Mariana Pjechova
KNKatie Nightingale
Katie Nightingale
VVVirginia-Maria Vlahava
Virginia-Maria Vlahava
MPMihil Patel
Mihil Patel
PTPeter Tomasec
Peter Tomasec
CD58 is an adhesion molecule that is known to play a critical role in costimulation of effector cells and is intrinsic to immune synapse structure. Herein, we describe a virally encoded gene that inhibits CD58 surface expression. Human cytomegalovirus (HCMV) UL148 was necessary and sufficient to promote intracellular retention of CD58 during HCMV infection. Blocking studies with antagonistic anti-CD58 mAb and an HCMV UL148 deletion mutant (HCMV∆UL148) with restored CD58 expression demonstrated that the CD2/CD58 axis was essential for the recognition of HCMV-infected targets by CD8+ HCMV-specific cytotoxic T lymphocytes (CTLs). Further, challenge of peripheral blood mononuclear cells ex vivo with HCMV∆UL148 increased both CTL and natural killer (NK) cell degranulation against HCMV-infected cells, including NK-driven antibody-dependent cellular cytotoxicity, showing that UL148 is a modulator of the function of multiple effector cell subsets. Our data stress the effect of HCMV immune evasion functions on shaping the immune response, highlighting the capacity for their potential use in modulating immunity during the development of anti-HCMV vaccines and HCMV-based vaccine vectors. Significance Human cytomegalovirus (HCMV) is the major infectious cause of developmental disorders in babies due to its capacity to cross the placenta. HCMV is also a major pathogen in transplant recipients and HIV–AIDS patients. Despite inducing the strongest immune responses observed for any human pathogen, HCMV evades host defenses and persists for life. Herein, we report another viral stealth strategy. HCMV UL148 reduces surface expression of a key cell adhesion molecule (CD58), impairing the ability of NK and T cells to be activated by HCMV-infected cells. Our findings highlight a role for CD58 in recognition of HCMV-infected cells and may be relevant for development of future antiviral therapies.

5 August 2016 in Scientific Reports
Verified
Journal Article
Open access
BLBetty Lau
Betty Lau
EPEmma Poole
Emma Poole
BKBenjamin Krishna
Benjamin Krishna
ISImmaculada Sellart
Immaculada Sellart
Mark R. WillsMark R. Wills
Mark R. Wills
Professor SinclairProfessor Sinclair
Professor Sinclair
The successful establishment and maintenance of human cytomegalovirus (HCMV) latency is dependent on the expression of a subset of viral genes. Whilst the exact spectrum and functions of these genes are far from clear, inroads have been made for protein-coding genes. In contrast, little is known about the expression of non-coding RNAs. Here we show that HCMV encoded miRNAs are expressed de novo during latent infection of primary myeloid cells. Furthermore, we demonstrate that miR-UL148D, one of the most highly expressed viral miRNAs during latent infection, directly targets the cellular receptor ACVR1B of the activin signalling axis. Consistent with this, we observed upregulation of ACVR1B expression during latent infection with a miR-UL148D deletion virus (ΔmiR-UL148D). Importantly, we observed that monocytes latently infected with ΔmiR-UL148D are more responsive to activin A stimulation, as demonstrated by their increased secretion of IL-6. Collectively, our data indicates miR-UL148D inhibits ACVR1B expression in latently infected cells to limit proinflammatory cytokine secretion, perhaps as an immune evasion strategy or to postpone cytokine-induced reactivation until conditions are more favourable. This is the first demonstration of an HCMV miRNA function during latency in primary myeloid cells, implicating that small RNA species may contribute significantly to latent infection.

2 February 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
BKBenjamin Krishna
Benjamin Krishna
KSKatja Spiess
Katja Spiess
EPE. L. Poole
E. L. Poole
BLB. Lau
B. Lau
SVSebastian Voigt
Sebastian Voigt
JSJ. H. Sinclair
J. H. Sinclair
Reactivation of human cytomegalovirus (HCMV) in transplant recipients can cause life-threatening disease. Consequently, for transplant recipients, killing latently infected cells could have far-reaching clinical benefits. In vivo, myeloid cells and their progenitors are an important site of HCMV latency, and one viral gene expressed by latently infected myeloid cells is US28. This viral gene encodes a cell surface G protein-coupled receptor (GPCR) that binds chemokines, triggering its endocytosis. We show that the expression of US28 on the surface of latently infected cells allows monocytes and their progenitor CD34+ cells to be targeted and killed by F49A-FTP, a highly specific fusion toxin protein that binds this viral GPCR. As expected, this specific targeting of latently infected cells by F49A-FTP also robustly reduces virus reactivation in vitro. Consequently, such specific fusion toxin proteins could form the basis of a therapeutic strategy for eliminating latently infected cells before haematopoietic stem cell transplantation.

19 April 2016 in Scientific Reports
Verified
Journal Article
Open access
BKB. A. Krishna
B. A. Krishna
BLB. Lau
B. Lau
Sarah Elizabeth JacksonSarah Elizabeth Jackson
Sarah Elizabeth Jackson
Mark R. WillsMark R. Wills
Mark R. Wills
JSJ. H. Sinclair
J. H. Sinclair
EPEmma Poole
Emma Poole
Human cytomegalovirus (HCMV) latency in the myeloid lineage is maintained by repressive histone modifications around the major immediate early promoter (MIEP), which results in inhibition of the lytic viral life cycle. We now show that pharmacological inhibition of histone deacetylases (HDACs) relieves this repression of the MIEP and induces transient expression of the viral lytic immediate early (IE) antigens but, importantly, not full virus reactivation. In turn, these latently infected cells now become targets for IE-specific cytotoxic T cells (CTLs) which are present at high frequency in all normal healthy HCMV positive carriers but would normally be unable to target latent (lytic antigen-negative) cells. This approach of transiently inducing viral lytic gene expression by HDAC inhibition, in otherwise latently infected cells, offers a window of opportunity to target and purge the latent myeloid cell reservoir by making these normally immunologically undetectable cells visible to pre-existing host immune responses to viral lytic antigens.

1 September 2016 in Journal of General Virology
Verified
Journal Article
Open access
BLBetty Lau
Betty Lau
EPEmma Poole
Emma Poole
EDEllen Van Damme
Ellen Van Damme
LBLieve Bunkens
Lieve Bunkens
MSMadeleine Sowash
Madeleine Sowash
Professor SinclairProfessor Sinclair
Professor Sinclair
Human cytomegalovirus, a member of the herpesvirus family, can cause significant morbidity and mortality in immune compromised patients resulting from either primary lytic infection or reactivation from latency. Latent infection is associated with a restricted viral transcription programme compared to lytic infection which consists of defined protein coding RNAs but also includes a number of virally encoded microRNAs (miRNAs). One of these, miR-UL112-1, is known to target the major lytic IE72 transcript but, to date, a functional role for miR-UL112-1 during latent infection has not been shown. To address this, we have analysed latent infection in myeloid cells using a virus in which the target site for miR-UL112-1 in the 3′ UTR of IE72 was removed such that any IE72 RNA present during latent infection would no longer be subject to regulation by miR-UL112-1 through the RNAi pathway. Our data show that removal of the miR-UL112-1 target site in IE72 results in increased levels of IE72 RNA in experimentally latent primary monocytes. Furthermore, this resulted in induction of immediate early (IE) gene expression that is detectable by IE-specific cytotoxic T-cells (CTLs); no such CTL recognition of monocytes latently infected with wild-type virus was observed. We also recapitulated these findings in the more tractable THP-1 cell line model of latency. These observations argue that an important role for miR-UL112-1 during latency is to ensure tight control of lytic viral immediate early (IE) gene expression thereby preventing recognition of latently infected cells by the host's potent pre-existing anti-viral CTL response.